Sexual function in patients treated for benign prostatic hyperplasia

Lancet

Volumn 361, Issue 9351, 2003, Pages 60-62

  Kassabian, Vahan S ^a  

^a Georgia Urology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; DOXAZOSIN; FINASTERIDE; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; AGING; BLADDER STONE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EJACULATION DISORDER; GOOD GENERAL CONDITION; HUMAN; IMPOTENCE; INCIDENCE; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SHORT SURVEY; SURGICAL TECHNIQUE; SYMPOSIUM; SYMPTOM; TREATMENT PLANNING; URINE RETENTION;

EID: 0037417535     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12164-2     Document Type: Short Survey

References (31)

1. Vermeulen A., Giagulli V.A., De Schepper P., Buntinx A. Hormonal effects of a 5alpha-reductase inhibitor (finasteride) on hormonal levels in normal and in patients with benign prostatic hyperplasia. Eur Urol. 20:(suppl 2):1991;82-86.
2. Berry S.J., Coffey D.S., Walsh P.C., Ewing L.L. The development of human benign prostatic hyperplasia with age. J Urol. 132:1984;474-479.
3. Kaiser F.E., Morley J.E. Gonadotropins, testosterone, and the aging male. Neurobiol Aging. 15:1994;559-563.
4. Morley J.E., Kaiser F.E. Sexual function with advancing age. Med Clin N Am. 73:1989;1483-1495.
5. Downs T.M., O'Leary M.P. Sexual dysfunction in patients with benign prostatic hyperplasia. Curr Opin Urol. 9:1999;9-14.
6. Marsigho W., Donnelly D. Sexual relations in later life: a national study of married persons. J Gerontol. 46:1991;5338-5344.
7. Diokno A.C., Brown M.B., Herzog A.R. Sexual function in the ederly. Arch Intern Med. 150:1990;197-200.
8. Bretschneider J.G., McCoy N.L. Sexual interest and behavior in healthy 80 to 102 year olds. Arch Sex Behav. 17:1988;109-129.
9. Janus S.S., Janus C.L. The Janus report on sexual behavior. 1993;25-90 John Wiley & Sons, New York.
10. Frankel S.J., Donovan J.L., Peters T.I., et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol. 51:1998;677-685.
11. Baniel J., Israilov S., Shrmueli J., Segenreich E., Livne P.M. Sexual function in131 patients with benign prostatic hyperplasia before prostatectomy. Eur Urol. 38:2000;53-58.
12. Blanker M.H., Bohmen A.M., Groeneveld F.P.M.J., et al. Correlates for erectile and ejaculatory dysfunction in older dutch men: a community-based study. J Am Geriatr Soc. 49:2001;436-442.
13. Tubaro A., Polito M., Giambroni L., Famulari C., Gange E., Ostardo E. Sexual function in patients with LUTS suggestive of BPH. Eur Urol. 40:(suppl):2001;19-22.
14. Vale J. Benign prostatic hyperplasia and erectile dysfunction - is there a link? Curr Med Res Opin. 16:(suppl 1):2000;s67.
15. Richard F., Lukacs B., Jardin A., et al. Results of an epidemiological survey of voiding disorders, quality of life and sexual function in men aged 50 to 80 years. Prog Urol. 11:2001;250-263.
16. Leliefeld H.H.J., Stovelaar H.J., Mcdonell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int. 89:2002;208-213.
17. Mebust W.K., Holtgrewe H.L., Cockett A.T., Peters P.C. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 141:1989;243-247.
18. Wasson J.H., Reda D.J., Bruskewitz R.C., Elinson J., Keller A.M., Henderson W.G. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Eng J Med. 332:1995;75-79.
19. Kinn A.-C., Helmy-Dhejne C., Larsson J. Sexual function one year after transurethral prostatic resection: patients' own assessments. Scan J Urol Nephrol. 32:1998;33-35.
20. Tscholl R., Largo M., Poppinghaus E., Recker F., Subotic B. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol. 153:1995;1491-1493.
21. Parsons C.I. Impotence following transurethral resection of the prostate. Rajfer J. Common problems in infertility and impotence. 1990;352-355 Year Book Medical, Chicago.
22. Tsai Y.S., Lin J.S., Tong J.C., et al. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: Long-term durability with Prostcare. Eur Urol. 39:2001;688-692.
23. Roehrborn C.G., Issa M.M., Bruskewitz R.C., et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-Month results of a prospective, multicenter US study. Urol. 51:1998;415-421.
24. Rodrigues N.N. Jr, Claro J.de A., Cortado P.L. Ejaculatory dysfunction after transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol. 8:1994;217-219.
25. Lepor H., Wilford W.O., Barry M.J., et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia: Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med. 335:1996;533-539.
26. Marberger M.J. Long term effects of finasteride in patients with benign prostatic hyperplasia: a double blind, placebo controlled, multicenter study. Urology. 51:1998;677-686.
27. Andriole G.L., Guess H.A., Epstein J.I., et al. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group: Proscar Long-term Efficacy and Safety Study. Urology. 52:1998;195-201.
28. Fawzy A., Braun K., Lewis G.P., Gaffney M., Ice K., Dias N. Doxazosin in the treatment of benign prostatic hyperplasiain normotensive patients: a multicenter study. J Urol. 154:1995;105-109.
29. Gillenwater J.Y., Conn R.L., Chrysant S.G., Roy J., Gaffney M., Ice K., Dias N. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double blind, placebo controlled, dose-response multicenter study. J Urol. 154:1995;110-115.
30. Lukacs B., Grange J.C., McCarthy C., Comet D. Clinical uroselectivity: a 3-year follow-up in general practice. BPH Group in General Practice. Eur Urol. 2:1998;28-33.
31. Zlotta A.R., Schulman C.C. BPH and sexuality. Eur Urol. 36:(suppl 1):1999;107-112.